COVID-19 lockdown sees incorporation of 16,000 new companies: Report

Of the 16,000 companies, 3,209 were registered in April 2020 alone

Moneycontrol News

June 24, 2020 / 13:29 IST

Despite slowdown in overall business activity due to the coronavirus pandemic, close to 16,000 new companies have been registered since India’s lockdown began on March 25. Of the 16,000 companies, 3,209 were registered in April alone.

The central registration office has been operating at 50 percent staff strength throughout the lockdown period, including weekends and holidays to ensure smooth incorporation of companies, sources told Business Standard.

Moneycontrol could not independently verify the report.

Comparatively, April saw 3,209 registrations compared to 10,383 in the same month in 2019. Of these over 1,000 were listed as ‘business service’, over 500 as ‘community and personal service’, close to 700 as ‘manufacturing’ and over 500 as ‘trading’ business.

Follow our LIVE Updates on the coronavirus pandemic here

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show